Ignacio Wistuba, MD
Enriched profileChair, Department of Translational Pathology, Moffitt Cancer Center · Moffitt Cancer Center
Ignacio Wistuba is Chair, Department of Translational Pathology, Moffitt Cancer Center at Moffitt Cancer Center. OpenAlex indexes 2,842 publications with 106,388 citations (h-index 156). Clarivate lists Ignacio Wistuba as a Highly Cited Researcher (Clinical Medicine, 2024-2025).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Ignacio I. Wistuba is Chair, Department of Translational Pathology, Moffitt Cancer Center. The public record shows 2,842 publications with 106,388 citations (h-index 156), centered on Lung Cancer Treatments and Mutations, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers. It also documents 6 NIH-funded awards (1993–2025).
- Most recent indexed publication: 2026 · Cancer immunology research
- Top research focus: Lung Cancer Treatments and Mutations
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 728.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612
Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
Updated 27 Aug 2026
6 NIH research awards on record, funded 1993–2025 per NIH RePORTER. The latest:
- 05 Tissue Biospecimen and Pathology Resource
University of Tx Md Anderson Can Ctr
FY2025$1,067,922P30CA016672 - ECOG-ACRIN Biospecimen Bank to Support NCTN
Ecog-Acrin Medical Research Foundation
FY2024$3,940,623U24CA196172 - MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC
University of Tx Md Anderson Can Ctr
FY2024$1,828,332U24CA224285
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.
Cancer immunology research
Article2026 - Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal.
Clinical cancer research
Clinical Trial2025 - The mutational landscape and functional effects of noncoding ultraconserved elements in human cancers.
Science advances
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02The 2015 World Health Organization Classification of Lung Tumors4,549 citations2015
- 03Somatic mutations affect key pathways in lung adenocarcinoma2,739 citations2008
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/Ignacio-I-Wistuba-38687933
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/ignacio-i-wistuba-98a735377
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - X / Twitter
x.com/MdWistuba
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/wafike_great-to-meet-dr-ignacio-wistuba-at-md-anderson-activity-7212239171246026752-bFfo
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - X / Twitter
x.com/MoffittNews/status/1929212477947941008
- X / Twitter
x.com/MoffittNews/status/1953807184963215630
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
- Surgical pathology training at Catholic University of Chile
Santiago; postgraduate diploma in oncologic diagnosis and postgraduate certificate in pathological anatomy …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →teamdraft.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
- Elected Member
IASLC Board of Directors (Board Member Europe, Any Gender/Any Specialty seat), 2023 election
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ilcn.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Clinical Medicine20242025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- Mary J. Matthews Pathology/Translational Research Award
International Association for the Study of Lung Cancer (IASLC), presented September 23, 2018 at WCLC Toronto …
2018verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Secondary affiliations
appointments beyond the home institution- Former (through ~May/June 2025): Professor and Chair
Department of Translational Molecular Pathology, Division of Pathology & Laboratory Medicine …
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog-ecog-acrin.org ↗ - Former Director (11 years, through 2025)
ECOG-ACRIN Central Biorepository and Pathology Facility (CBPF) at MD Anderson; succeeded by Dr. Scott D. Jewell in this specific directorship following the Moffitt move …
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog-ecog-acrin.org ↗ - Co-Investigator
NCI Early Detection Research Network (EDRN), UT MD Anderson site
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →edrn.cancer.gov ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Christine Chung, MD
Moffitt Cancer Center
Peter Forsyth, MD
Moffitt Cancer Center
Eric Haura, MD
Moffitt Cancer Center
Jonathan Strosberg, MD
Moffitt Cancer Center